Clinical Efficacy of Modified Qingyitang Combined with Blood Purification on Severe Acute Pancreatitis Complicated with Multiple Organ Dysfunction Syndrome

Qiong YI; Fei-yue DAI; Zhi-hua GUO; Jian-xiang WANG; Dong-liang LIU; Quan-cheng LIN; Can DING

doi:10.13422/j.cnki.syfjx.20200428

您当前的位置：

首页 >

文章列表页 >

Clinical Efficacy of Modified Qingyitang Combined with Blood Purification on Severe Acute Pancreatitis Complicated with Multiple Organ Dysfunction Syndrome

Clinic | 更新时间：2021-02-09

- Clinical Efficacy of Modified Qingyitang Combined with Blood Purification on Severe Acute Pancreatitis Complicated with Multiple Organ Dysfunction Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 8, Pages: 95-104(2020)
- 作者机构：
  
  1.湖南中医药大学　第一附属医院，长沙　 410007
  2.湖南中医药大学，长沙　 410208
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20200428
  CLC： R22; R242; R2-031;R287
- Received：14 July 2019，
  
  Published Online：06 November 2019，
  
  Published：20 April 2020
- 稿件说明：
移动端阅览
Qiong YI, Fei-yue DAI, Zhi-hua GUO, et al. Clinical Efficacy of Modified Qingyitang Combined with Blood Purification on Severe Acute Pancreatitis Complicated with Multiple Organ Dysfunction Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(8): 95-104.
DOI：

Qiong YI, Fei-yue DAI, Zhi-hua GUO, et al. Clinical Efficacy of Modified Qingyitang Combined with Blood Purification on Severe Acute Pancreatitis Complicated with Multiple Organ Dysfunction Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(8): 95-104. DOI： 10.13422/j.cnki.syfjx.20200428.

摘要

目的：

探讨清胰汤加减联合连续性血液净化辅助治疗腑实热结型重症急性胰腺炎(SAP)合并多器官功能障碍(MODS)的疗效。

方法：

选择2015年5月至2019年5月在湖南中医药大学第一附属医院重症医学科(ICU)住院，西医符合SAP合并MODS诊断标准，中医诊断符合腑实热结证的患者共100例，随机分为对照组和观察组，各50例。对照组患者予以禁食禁饮、胃肠减压、胰蛋白酶抑制剂、胃黏膜保护、早期空肠营养、减轻炎症反应、连续性床旁血液净化(CBP)、机械通气、循环支持等综合治疗，观察组患者在常规综合治疗的基础上，辨证论治经鼻空肠管注入清胰汤加减，疗程为7 d。记录患者腹痛腹胀缓解时间、首次排气排便时间、住ICU时间、样本脱落数、死亡原因和例数；治疗开始前、治疗第3，7天分别测定相关指标，包括胰腺炎评价指标血淀粉酶(AMS)、血脂肪酶(LPS)、改良的CT严重指数评分(MCTSI)；炎症反应指标采用白细胞介素-6(IL-6)和超敏C反应蛋白(hs-CRP)；器官功能和组织灌注评价指标包括急性生理与慢性健康评分(APACHE-Ⅱ)、血清乳酸(Lac)、中心静脉压(CVP)、动脉血氧分压(PaO

)、氧合指数(PaO

/FiO

)、谷氨酸-丙酮酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、碱性磷酸酶(ALP)、谷氨酰转肽酶(

-GGT)、尿量、肌酐(CREA)、尿素氮(UREA)、肾小球滤过率(GFR)、肌酸激酶(CK)、肌酸激酶同工酶(CKMB)、乳酸脱氢酶(LDH)、肌红蛋白(Mb)；中医治疗评分采用急性胰腺炎腑实热结证证候评分。

结果：

观察组中医证候疗效总有效率为86.67%(39/45)，高于对照组的73.91%(34/46)(

＝13.524，

0.01)；治疗第7天，两组患者的症状和指标均得到改善；与本组治疗前比较，观察组和对照组治疗后第3，7天，AMS，LPS，IL-6，hs-CRP，MCTSI评分，APACHE-Ⅱ评分，Lac，CVP，PaO

，PaO

/FiO

，ALT，AST，ALP，

-GGT，尿量，CREA，UREA，GFR，CK，CKMB，LDH，Mb的水平均显著改善(

0.05)；与对照组第3，7天比较，观察组相应时间点的AMS，LPS，IL-6，hs-CRP，MCTSI评分，APACHE-Ⅱ评分，Lac，CVP，PaO

，PaO

/FiO

，ALT，AST，ALP，

-GGT，尿量，CREA，UREA，GFR，CK，CKMB，LDH，Mb明显改善(

0.05)。与对照组比较，观察组患者腹痛、腹胀缓解时间、首次排气/排便时间、住ICU时间明显缩短(

0.05)，观察组患者的死亡率明显降低(

0.05)。

结论：

SAP患者并发MODS时，使用血液净化联合清胰汤加减，可以促进胰腺修复，抑制炎症反应，改善脏器功能，对于改善症状，缓解中医证候，延缓病程进展，减少住院时间，降低病死率起到了重要作用。

Abstract

Objective:

To explore the effect of modified Qingyitang combined with continuous blood purification in the adjuvant treatment of severe acute pancreatitis (SAP) complicated with multiple organ dysfunction (MODS) caused by heat accumulation of viscera.

Method:

Totally 100 cases of patients of SAP complicated with MODS

who were diagnosed as heat accumulation of viscera by traditional Chinese medicine(TCM) and treated in ICU of the First Affiliated Hospital of Hunan University of Chinese Medicine during May 2015 and May 2019

were randomly divided into two groups

namely control group and observation group

with 50 cases in each group. The patients in control group were treated with fasting and abstinence

gastrointestinal decompression

inhibition of trypsin secretion

gastric mucosal protection

early jejunal nutrition

reduction of inflammatory reaction

continuous blood purification (CBP)

mechanical ventilation and circulatory support. The patients in observation group were treated by nasojejunal tube according to syndrome differentiation in addition to routine comprehensive therapy. Modified Qingyitang was injected for 7 days. The remission time of abdominal pain and distention

the time of first exhaust and defecation

the time of ICU residence

the number of samples falling off

the cause of death and the number of cases were recorded. Relevant indexes were measured before treatment

on the 3

and 7

day of treatment

including the evaluation indexes of pancreatitis: blood amylase (AMS)

blood lipase (LPS)

and modified computed tomography severity index (MCTSI)

inflammatory response indexes were interleukin-6 (IL-6) and hypersensitive C-reactive protein (hs-CRP). Organ function indexes included APACHE-Ⅱ

arterial partial pressure of oxygen (PaO

)

oxygenation index (PaO

/FiO

)

alanine aminotransferase (ALT)

aspartate aminotransferase (AST)

alkaline phosphatase (ALP)

glutamyltransferase (

-GGT)

urine volume

creatinine (CREA)

urea nitrogen (UREA)

glomerular filtration rate (GFR)

creatine kinase (CK)

creatine kinase isoenzymes (CKMB)

lactate dehydrogenase (LDH)

myoglobin (Mb). Tissue perfusion evaluation indexes included acute physiology and chronic health score

serum lactic acid (Lac) and central venous pressure (CVP). TCM treatment score was based on the syndrome score of acute pancreatitis with heat accumulation of viscera syndrome.

Result:

The total effective rate of TCM syndromes was 86.67%(39/45) in observation group and 73.91%(34/46) in control group (

=13.524

0.01). On the 7

day of treatment

the symptoms and indicators of the two groups were improved. Compared with before treatment

AMS

LPS

IL-6

hs-CRP

MCTSI

APACHE-Ⅱ

Lac

CVP

PaO

/FiO

ALT and AST were improved on the 3

and 7

day after treatment in observation group and control group. The levels of AMS

LPS

IL-6

hs-CRP

MCTSI

APACHE-Ⅱ

Lac

CVP

PaO

/FiO

ALT

AST

ALP

-GGT

urine volume were significantly improved (

0.05). Compared with control group on the 3

and 7

day

the levels of AMS

LPS

IL-6

hs-CRP

MCTSI

APACHE-Ⅱ

Lac

CVP

PaO

/FiO

ALT

AST

ALP

-GGT

urine volume were significantly improved (

0.05). CREA

UREA

GFR

CKMB

LDH and Mb were significantly improved (

0.05). Compared with control group

the abdominal pain

abdominal distension relief time

first exhaust/defecation time

ICU stay time in observation group were significantly shortened (

0.05)

and the mortality rate in observation group was significantly reduced (

0.05).

Conclusion:

Patients of SAP accompanied with MODS can be treated with blood purification combined with modified Qingyitang by promoting pancreas repair

inhibiting inflammation and improving organ function. It plays an important role in improving symptoms

alleviating TCM syndromes

delaying progression of disease

reducing hospital stay and reducing mortality.

关键词

Keywords

references

孔娟，李鹏．急性重症胰腺炎合并多器官功能损伤55例临床分析 [J]．江苏医药， 2017 ， 43 ( 1 )： 75 - 76 .

张裕超，蒙文韬．重症急性胰腺炎的治疗进展 [J]．世界最新医学信息文摘， 2018 ， 18 ( 41 )： 28-29，33 .

王涛，张凡，魏萌，等．持续血液净化治疗对重症胰腺炎合并MODS患者炎症反应状态及靶器官损伤的影响 [J]．海南医学院学报， 2017 ， 23 ( 9 )： 1210-1212，1216 .

潘以丰，蔡海荣，陈锦锋，等．通腑泄热、行气活血法治疗重症急性胰腺炎的疗效观察 [J]．中国中医急症， 2018 ， 27 ( 5 )： 895-896，899 .

中华医学会外科学分会胰腺外科学组 . 急性胰腺炎诊治指南(2014) [J]．中华普通外科学文献：电子版， 2015 ， 9 ( 2 )： 86 - 89 .

胥清蓉，陈晓梅，石宝春，等．不同血液净化对重症急性胰腺炎全身炎症综合征的临床疗效评价 [J]．西部医学， 2018 ， 30 ( 2 )： 238 - 241 .

汪翊，冷琦，黄子星，等．三种CT评分与急性胰腺炎严重程度床边指数评分评估重症急性胰腺炎的相关性研究 [J]．中国普外基础与临床杂志， 2015 ， 22 ( 12 )： 1520 - 1524 .

张声生，李慧臻．急性胰腺炎中医诊疗专家共识意见(2017) [J]．中华中医药杂志， 2017 ， 32 ( 9 )： 4085 - 4088 .

姚乐，赵浩，张洁，等．急性生理和慢性健康状况评分Ⅱ和序贯器官衰竭评估评分对急诊重症监护病房脓毒症患者的预后评估价值 [J]．中国临床医生杂志， 2018 ， 46 ( 3 )： 276 - 278 .

中华人民共和国卫生部．中药新药临床研究指导原则 [M]．北京：中国医药科技出版社， 2002 ： 86 .

磨庆福．重症急性胰腺炎的发病原因及发病机制研究进展 [J]．胃肠病学和肝病学杂志， 2014 ， 23 ( 9 )： 1107 - 1110 .

D WU , M TANG , Y ZHAO , et al . Impact of seasons and festivals on the onset of acute pancreatitis in Shanghai, China [J]． Pancreas ， 2017 ， 46 ( 4 )： 496 - 503 .

Y ZHU , X PAN , H ZENG , et al . A study on the etiology，severity, and mortality of 3 260 patients with acute pancreatitis according to the revised atlanta classification in Jiangxi, China over an 8-year period [J]． Pancreas ， 2017 ， 46 ( 4 )： 504 - 509 .

冯小萌，王原．急性胰腺炎发病机制及治疗研究进展 [J]．世界最新医学信息文摘， 2017 ， 17 ( 40 )： 26 - 30 .

陈王芬．重症急性胰腺炎早期并发多脏器功能障碍综合征的危险因素探究 [J]．临床医药文献电子杂志， 2017 ， 4 ( 52 )： 10186，10188 .

龙跃辉．乌司他丁联合奥曲肽治疗急性胰腺炎的临床观察 [J]．中国医药指南， 2019 ， 17 ( 9 )： 149 - 150 .

于嫔．连续性血液净化治疗重症急性胰腺炎合并多器官功能障碍综合征的疗效观察 [J]．医学理论与实践， 2019 ， 32 ( 3 )： 371 - 372 .

蒙晓冰，黄秋兰，林碧秀，等．中医药治疗急性胰腺炎的临床研究进展 [J]．广西中医药大学学报， 2019 ， 22 ( 1 )： 49 - 52 .

赵洪涛．活血清胰汤灌肠辅助经内镜逆行性胰胆管造影术治疗肝郁气滞型急性重症胰腺炎疗效及对免疫功能的影响 [J]．现代中西医结合杂志， 2017 ， 26 ( 22 )： 2455 - 2458 .

孙文杰，陈亚峰，李红昌，等．大承气汤类方治疗急性胰腺炎临床研究进展 [J]．中国实验方剂学杂志， 2019 ， 25 ( 12 )： 221 - 226 .

杨国红，张翠，王晓，等．大承气汤、大柴胡汤四联辨证治疗胃肠实热和肝胆湿热证早期急性胰腺炎及对血清炎症因子的影响 [J]．中国实验方剂学杂志， 2018 ， 24 ( 8 )： 165 - 170 .

杜高能，蒙绪君．清胰汤治疗重症胰腺炎疗效及对炎症因子的影响 [J]．山东中医杂志， 2019 ， 38 ( 3 )： 238 - 241 .

雷霏，冯晓洁，王薇．柴胡皂苷对慢性胆源性胰腺炎大鼠胰腺外分泌功能的影响及机制探讨 [J]．临床和实验医学杂志， 2018 ， 17 ( 17 )： 1810 - 1815 .

曹砚杰，李琨琨，靳莉，等．大黄提取物对急性胰腺炎模型大鼠的治疗作用及机制 [J]．中国老年学杂志， 2018 ， 38 ( 6 )： 1448 - 1451 .

汤建军，林晶晶，韩小乐，等．黄芩苷对急性胰腺炎大鼠胰腺细胞自噬及Akt/mTOR通路的影响 [J]．中国中医急症， 2018 ， 27 ( 5 )： 858-861，870 .

李培武，杨莉，丁卓奇，等．丹参注射液对重症急性胰腺炎大鼠心脏的保护作用 [J]．中药新药与临床药理， 2019 ， 30 ( 2 )： 184 - 188 .

田喆，谢晓晶，孙书林，等．黄连素对重症急性胰腺炎大鼠炎症反应的影响 [J]．海南医学， 2018 ， 29 ( 4 )： 448 - 451 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Protective Effect of Xuebijing on Lung Injury in Rats with Severe Acute Pancreatitis by Blocking FPRs/NLRP3 Inflammatory Pathway

Xuebijing Injection Regulates Mitochondrial N-formyl Peptides/NLRP3 Inflammatory Pathway to Treat Severe Acute Pancreatitis in Rats

Clinical Efficacy of Dahuang Zhuyu Decoction for Oral Administration and Enema on Severe Acute Pancreatitis with Syndromes of Blood Stasis, Toxin and Its Effect on Serum Inflammatory Factors

Systematic Review and Meta-analysis on Modified Dachengqi Decoction in Treatment of Severe Acute Pancreatitis

Related Author

LIU Hongbin

ZHANG Guixian

LIU Dawei

LI Xia

LI Xijing

SHI Pengcheng

FENG Zhiqiao

CAI Jun

Related Institution

Tianjin Institute of Medical and Pharmaceutical Science

Tianjin Chase Sun Pharmaceutical Co. Ltd.

Health Commission of Heping District

Graduate School， Tianjin Medical University

Henan Provincial People's Hospital

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰